Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0388220140210020054
Journal of the Korean Rheumatism Association
2014 Volume.21 No. 2 p.54 ~ p.63
The Present and Future of Clinical Research for Korean Lupus Patients
Kim Dam

Cho Soo-Kyung
Sung Yoon-Kyoung
Abstract
Systemic lupus erythematosus (SLE) is considered to be the prototype of systemic autoimmune disease because it involves the most immune cells and it can affect all organs of the hu-man body. Despite the advances in understanding the etiology and pathogenesis of SLE, a sobering fact is that only a few drugs have been licensed for its treatment. This may be asso-ciated with the difficulties in performing clinical trials due to its diverse clinical manifestations and comorbidities of SLE, as well as difficulties in determining the disease outcome. To determine the natural course and drug response of SLE pa-tients, various observational studies have been conducted in Western countries. However, in Korea, sufficiently powered prospective clinical studies are scarce. In this review, we con-ducted a systematic review to be aware of the current status of clinical studies in Korean SLE patients. Identifying the top-ics for clinical studies that have been performed helps de-termine how the clinical research should be conducted for Korean SLE patients.
KEYWORD
Lupus erythematosus, Systemic, Clinical study, Korean
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø